Geisinger Health System Archives - Medical Design Sourcing

Investors find $257 million to commit to Thrive’s CancerSEEK

Investors once again lined up behind a potentially revolutionary cancer diagnostic being developed by Thrive Earlier Detection Corp.

The one-year-old start up raised a $257 million Series B round from a syndicate of venture and crossover investors, including round leaders Casdin Capital and Section 32 and new investors Bain Capital Life Sciences, Brown Advisory, Driehaus Capital Management, Intermountain Ventures, Janus Henderson Investors, Lux Capital, Moore Strategic Ventures, Perceptive Advisors, Rock Springs Capital, Sands Capital, funds and accounts advised by T. Rowe Price Associates, Inc., and other undisclosed investors.

The new round is more than double the $110 million Series A round raised by the company last May. The company said all of its first-round investors participated in the new financing including Casdin, Biomatics, Third Rock Ventures, BlueCross BlueShield Venture Partners, Invus, Exact Sciences, Cowin Venture, Camden Partners, Gamma 3 LLC …

Siemens, Geisinger ink 10-year deal

Siemens Healthineers (ETR: SHL) and Geisinger Health have signed a 10-year deal for Siemens to provide digital health innovations, diagnostic imaging equipment and on-site staff support.

Siemens will also provide education and workflow resources to the staff of Danville, Pa.-based Geisinger Health. The contract marks an expansion of a previous relationship between the health system and Siemens.

Get the full story on our sister site, Medical Design & Outsourcing.

Study finds delays in seeking stroke treatment amid COVID-19

Ischemic stroke patients are showing up to the hospital an average of 160 minutes later during the COVID-19 pandemic than during a similar timeframe in 2019, according to a new study.

The delay is affecting both stroke survival and recovery, add stroke surgeons from the Society of NeuroInterventional Surgery (SNIS).

The first study to confirm suspected stroke patient avoidance assessed 710 patients presenting with acute ischemic strokes at 12 stroke centers across six states. It compared the period of February and March 2019 (the baseline period) to February 2020 (the “pre-COVID-19” period) and March 2020 (the “COVID-19” period). In addition to the delay in treatment, the study also found a marked decrease in overall reported stroke patients, from 223 to 167, in these same treatment centers from February to March 2020 with the onset of the COVID-19 pandemic. It was published in the Journal of NeuroInterventional Surgery (JNIS).

Get the full story on our …